Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus prasugrel for microvascular dysfunction after revascularized STEMI
NL-OMON44678Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in myocardial infarction (MI) comparing Ticagrelor maintenance dose with Prasugrel maintenance dose (2 arms). Primary endpoint: Microvascular function in the infarct-related vessel at 30 days. Started May 2015; status: active, not recruiting.
02
Drugs
ticagrelorprasugrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON44678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44678.